https://www.selleckchem.com/pr....oducts/apr-246-prima
the outcomes are blinded to group assignment. Numbers to be randomised (sample size) 100 participants will be randomised to each group (thus 200 participants in total). Trial status Protocol Version V 1.2, 16.04.2020. Recruitment began 27th April 2020 and is anticipated to be completed by December 2020. Trial registration The trial was registered before trial start in trial registries (EudraCT No. 2020-001408-41, registered 21st April 2020, and DRKS No. DRKS00021238, registered 22nd April 202. Full protocol The full protoco